Harmony Biosciences Holdings, Inc. (HRMY)
28.48
-0.42
(-1.47%)
USD |
NASDAQ |
Mar 03, 11:33
Harmony Biosciences Holdings Shareholders Equity (Quarterly) : 870.22M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Castle Biosciences, Inc. | 470.87M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Amicus Therapeutics, Inc. | 274.24M |
| Iovance Biotherapeutics, Inc. | 698.58M |
| Apellis Pharmaceuticals, Inc. | 370.15M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.272B |
| Total Liabilities (Quarterly) | 401.41M |
| Debt to Equity Ratio | 0.2701 |
| Current Ratio | 3.597 |
| Net Debt Paydown Yield | -0.09% |